Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Rare Liver Disease Drug Contenders Among Latest EU Filings

MAA For Bayer’s Finerenone Also Filed

Dec 17 2020

• By Neena Brizmohun

Female person holding red human liver model at white body — PFIC leads to cirrhosis and liver failure within the first 10 years of life • Source: Shutterstock

Related Content

Keeping Track: Keytruda Adds TNBC Claim; Finerenone, Brincidofovir, HTX-011 Submitted; CRL For Supernus’ ADHD Drug

Nov 14 2020

Biogen’s Aducanumab Falls Hard At Panel Review, Leaving US FDA In A Tight Spot

Nov 08 2020

Hurry Up And Approve: EMA Brings Vaccine Decision Forward After Political Pressure

Dec 16 2020

Keeping Track: US FDA Approvals For Ibsrela, Gvoke And Nucala; A BTD For Tepotinib

Sep 13 2019

Aducanumab Filed In Japan Despite Recent US Setback

Dec 10 2020

Related Companies

Albireo Pharma Inc.

Mirum Pharmaceuticals, Inc.

Bayer AG

Merck & Co., Inc.

Eli Lilly and Company

Orphazyme A/S

Biogen, Inc.

Eisai Co., Ltd.

Pfizer Inc.

BioNTech SE

Additional Topics

Europe Drug Review Review Pathway Approvals Market Access Regulation Vaccines Coronavirus COVID-19 Cancer Liver & Hepatic Orthopedics Renal Metabolic Disorders Neurology Infectious Diseases BioPharmaceutical

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window